跳至主要内容
临床试验/NCT03581695
NCT03581695已完成不适用

Inflammatory Biomarkers of Pediatric Pulmonary Hypertension: a Prospective Cohort Study

The Hospital for Sick Children2 个研究点 分布在 1 个国家目标入组 74 人开始时间: 2018年6月20日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
74
试验地点
2
主要终点
Measurement of HGMB1

研究概览

简要总结

To investigate if the inflammatory protein, high mobility group box 1 (HMGB1), along with other inflammatory mediators, is elevated in pediatric patients with congenital heart disease (CHD) and pulmonary hypertension as compared to those with CHD alone, or with healthy controls.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
1 Day 至 18 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • patients of any age with congenital cardiac disease coming for catheterization of the right heart, or both the right and left heart.

排除标准

  • active systemic infection
  • current active cancer
  • active cancer treatment
  • prior bone marrow transplant
  • prior solid organ transplant

研究组 & 干预措施

Pulmonary Hypertension and Congenital Heart Disease

Pulmonary Hypertension and Congenital Heart Disease

干预措施: Blood test (Other)

Congenital Heart Disease

Congenital Heart Disease

干预措施: Blood test (Other)

Healthy Controls

Healthy Controls

干预措施: Blood test (Other)

结局指标

主要结局

Measurement of HGMB1

时间窗: 1 day

Measurement of HGMB1

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Katherine Taylor

Staff Anesthesiologist

The Hospital for Sick Children

研究点 (2)

Loading locations...

相似试验